Diabetes diagnosis

Diagnosis and Classification of Diabetes

  • Standards of Care in Diabetes by the American Diabetes Association (ADA)

    • Annual updates by the ADA Professional Practice Committee.

    • Provides clinical practice recommendations for diabetes care, treatment goals, and evaluation tools.

Overview of Diabetes Mellitus

  • Diabetes mellitus is a group of disorders affecting carbohydrate metabolism, characterized by:

    • Underutilization of glucose as energy.

    • Overproduction of glucose via gluconeogenesis and glycogenolysis.

    • Resulting in hyperglycemia (high blood sugar levels).

Diagnosis of Diabetes

  • Diagnostic Criteria:

    1. Increased glucose concentrations in venous plasma.

    2. Increased A1C levels in the blood.

  • Classification:

    • Type 1 Diabetes Mellitus (T1DM)

    • Type 2 Diabetes Mellitus (T2DM)

    • Gestational Diabetes Mellitus (GDM)

    • Other specific types (e.g., monogenic diabetes, endocrine pancreatic disorders).

Diagnostic Tests for Diabetes

  • Tests for Diagnosis:

    • A1C Test:

      • A1C ≥ 6.5% (≥ 48 mmol/mol) indicates diabetes.

    • Plasma Glucose Tests:

      • Fasting Plasma Glucose (FPG) ≥ 126 mg/dL (≥ 7.0 mmol/L).

      • 2-hour Plasma Glucose (2-h PG) during OGTT ≥ 200 mg/dL (≥ 11.1 mmol/L).

      • Random Plasma Glucose ≥ 200 mg/dL (≥ 11.1 mmol/L) with classic symptoms of hyperglycemia or hyperglycemic crisis.

  • Confirmatory Testing:

    • Two abnormal test results from different tests at the same time or confirmatory testing required if initial results are in the diagnostic range, but no classic symptoms of hyperglycemia.

Screening and Diagnosis

  • Appropriate tests:

    • FPG, 2-h PG during OGTT, and A1C for screening and diagnosis.

  • Variability in Tests:

    • Different tests may diagnose varying numbers of individuals with diabetes, especially among prediabetes cases.

  • Insufficient evidence currently for continuous glucose monitoring for screening.

Impaired Glucose Tolerance and Prediabetes

  • Prediabetes Indications:

    • IFG (Impaired Fasting Glucose): FPG 100-125 mg/dL (5.6-6.9 mmol/L).

    • IGT (Impaired Glucose Tolerance): 2-h PG 140-199 mg/dL (7.8-11.0 mmol/L).

    • A1C 5.7-6.4% (39-47 mmol/mol).

  • Individuals with prediabetes are at increased risk for diabetes and cardiovascular diseases.

Classification of Diabetes Types

  1. Type 1 Diabetes (T1D):

    • Autoimmune destruction of beta cells, leading to insulin deficiency.

  2. Type 2 Diabetes (T2D):

    • Progressive insulin secretory defect often in conjunction with insulin resistance.

  3. Monogenic Diabetes:

    • Genetic mutations causing direct dysregulation of insulin secretion.

  4. Gestational Diabetes (GDM):

    • Occurs during pregnancy; recognized by providing immediate concerns for subsequent diabetes.

Distinguishing Features for Types 1 and 2 Diabetes

  • For Type 1 Diabetes:

    • Typically presents with symptoms like polyuria, polydipsia, and weight loss.

    • Often characterized by ketoacidosis at presentation.

    • Family or personal history of autoimmune conditions may exist.

  • For Type 2 Diabetes:

    • Commonly chronic, with gradual onset and potential obesity-related conditions.

    • Can also present with comorbidities like hypertension and dyslipidemia.

Tools for Diagnosis

  • C-Peptide and Autoantibodies Testing:

    • Useful for differentiating between Type 1 and Type 2 diabetes where there is unclear classification.

Special Considerations

  • Pregnant Women:

    • Early screening for diabetes is critical in those with history or predisposition to GDM.

  • Post-Transplant Diabetes and Monogenic Syndromes:

    • Monitoring for diabetes in transplant patients must account for immunosuppressive therapy and genetic implications.

Gestational Diabetes and Screening Protocols

  • First Trimester Screening:

    • Important to identify potentially undiagnosed prediabetes or diabetes that complicates pregnancy.

    • Use two approaches:

      • One-step 75-g OGTT or Two-step approach with a 50-g non-fasting test followed by a 100-g OGTT if indicated.

  • Postpartum Screening:

    • Individuals with GDM require regular screening to prevent further progression to diabetes.

Additional Tips for Screening Protocols

  • Testing should be structured around risk factors and coordinated within health care systems to ensure proper follow-up.

  • Lifestyle interventions should be encouraged to mitigate progression from prediabetes to diabetes.